Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,767
Closed -$204K 39
2023
Q2
$204K Buy
+1,767
New +$201K 0.11% 40
2015
Q4
Sell
-54,708
Closed -$2.58M 262
2015
Q3
$2.58M Buy
54,708
+269
+0.5% +$14.3K 0.06% 136
2015
Q2
$2.96M Buy
54,439
+3,673
+7% +$206K 0.04% 131
2015
Q1
$2.78M Sell
50,766
-6,781
-12% -$384K 0.04% 154
2014
Q4
$3.12K Sell
57,547
-3,693
-6% -$206K 0.03% 146
2014
Q3
$3.46K Sell
61,240
-3,771
-6% -$212K 0.03% 150
2014
Q2
$3.59M Sell
65,011
-10,577
-14% -$577K 0.15% 146
2014
Q1
$4.09M Sell
75,588
-274,339
-78% -$14.2M 0.18% 134
2013
Q4
$16.7M Buy
349,927
+84,028
+32% +$3.84M 0.42% 55
2013
Q3
$12.1M Buy
265,899
+82,974
+45% +$3.79M 0.35% 65
2013
Q2
$8.11M Buy
+182,925
New +$8.17M 0.12% 139

Other funds holding MRK

NatWest Group's MRK Position: Q3 2023 in Review

NatWest Group sold out of Merck (MRK) in Q3 2023, closing a stake of 1,767 shares — an estimated $204K sold.

NatWest Group first reported a position in MRK in Q2 2013 and held it in 11 quarters. The position peaked at $16.7M in Q4 2013. 3,213 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • NatWest Group reported no remaining Merck position as of Q3 2023 after selling out during the quarter.
  • NatWest Group sold 1,767 Merck shares in Q3 2023, an estimated $204K.
  • NatWest Group first reported a position in Merck in Q2 2013 and held it in 11 quarters.
  • NatWest Group's Merck position peaked at $16.7M in Q4 2013.
  • 3,213 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on NatWest Group's 13F filing for Q3 2023, filed 12 Oct 2023.